08:17 AM EDT, 04/04/2024 (MT Newswires) -- Health care stocks were gaining pre-bell Thursday, with the Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) 0.4% higher.

MacroGenics ( MGNX ) said interim safety data from the phase 2 trial of vobra duo in people with metastatic castration-resistant prostate cancer is set for a May release after a company abstract wasn't accepted by the American Society of Clinical Oncology for presentation at a meeting starting May 31. The company's shares were up 9.4% premarket Thursday.